Iterum Therapeutics upgraded by H.C. Wainwright with a new price target
$ITRM
Biotechnology: Pharmaceutical Preparations
Health Care
H.C. Wainwright upgraded Iterum Therapeutics from Neutral to Buy and set a new price target of $2.50
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 7/27/2021 | Sell → Hold | Gabelli & Co. | |
| 7/26/2021 | Buy → Neutral | HC Wainwright & Co. |
3 - Iterum Therapeutics plc (0001659323) (Issuer)
4 - Iterum Therapeutics plc (0001659323) (Issuer)
4 - Iterum Therapeutics plc (0001659323) (Issuer)
8-K - Iterum Therapeutics plc (0001659323) (Filer)
8-K - Iterum Therapeutics plc (0001659323) (Filer)
10-Q - Iterum Therapeutics plc (0001659323) (Filer)
4 - Iterum Therapeutics plc (0001659323) (Issuer)
4 - Iterum Therapeutics plc (0001659323) (Issuer)
4 - Iterum Therapeutics plc (0001659323) (Issuer)